top of page
Espacio de trabajo moderna

STRATEGIC CONSULTING SERVICES 

YOUR PARTNER, EVERY STEP OF THE WAY

CLINICAL TRIAL STRATEGY 

We're looking for you

Collaborate with us to improve patient care as fast and cost-efficient as possible. 

 

At MEDSIR, we leverage our relationships, access to services, and strategic perspective to become an invaluable partner in every step of the development of your asset. Trust us to bring our expertise and passion for innovation to your project to put it on the path to success. 

>31
INDUSTRY FUNDERS

>48
ONCOLOGY TRIALS

>232  
SITES

>432  
RESEARCH
COLLABORATORS

>400 
IDEAS
GENERATED

>88  
STAFF
DEDICATED

>2310 
PATIENTS
RECRUITED

CLINICAL DEVELOPMENT CONSULTING 

We're looking for you

Our Strategic Services guide clients through planning, managing, analyzing, and reporting clinical trials. We believe that success is a team effort, and we’ll be with you along the way to ensure that your project achieves the desired outcomes. 

Icon_Results bg.png

SET UP NEW TRIALS. Utilizing our network of Key Opinion Leaders (KOLs), we can develop your clinical strategy and complete trial roadmap, including study design and protocol optimization. We prioritize collaboration and work closely with you to maintain the key interests of your company throughout the process. 

SERVICES INCLUDE: Think Tanks for pharma companies, Advisory Boards for biotech companies, Expert Committees 
 

 

WHY CHOOSE MEDSIR?

home_fondo_tolife_barra.jpg
  • Network of oncology experts and KOLs who provide feedback on your pipeline 

  • Multinational operational structure that is not limited by a pre-defined network of sites 

  • Flexible clinical development support to fit your needs 

  • Consultative support to develop end-to-end clinical trial strategies 

SOME OF OUR CLINICAL TRIALS

We're looking for you
3d-rendering-luxury-new-background-white-honeycomb-hexagon-pattern-honeycomb-3d-illustrati

PHERGAIN

BREAST

Chemotherapy-free trastuzumab and pertuzumab in HER2-positive breast cancer: A FDG-PET response-adapted strategy

3d-rendering-luxury-new-background-white-honeycomb-hexagon-pattern-honeycomb-3d-illustrati

SLLIP

LUNG

Spanish Lung Liquid vs. Invasive biopsy Program (SLLIP)

3d-rendering-luxury-new-background-white-honeycomb-hexagon-pattern-honeycomb-3d-illustrati

ORPHEUS

PENIS

Phase II Study of the Efficacy of INCMGA00012 in Penile Squamous Cell Carcinoma

3d-rendering-luxury-new-background-white-honeycomb-hexagon-pattern-honeycomb-3d-illustrati

PARSIFAL

BREAST

Palbociclib with fulvestrant or letrozole for HER-, ER+ metastatic breast cancer

SOME CLINICAL EXPERTS COLLABORATING
WITH MEDSIR

We're looking for you

JAVIER

CORTÉS

Medical Oncologist 
MD, PhD

PETER SCHMID

Medical Oncologist MD, PhD

ANTONIO

LLOMBART

Medical Oncologist 
MD, PhD

JORDI 

REMON

Medical Oncologist 
MD, PhD

MARTA 
VAZ-BAPTISTA

Medical Oncologist 
MD

JOSEPH GLIGOROV

Medical Oncologist 
MD, PhD

FREDERIK MARMÉ

Gynecologist 
MD

NOEMÍ REGUART

Medical Oncologist 
MD, PhD

MARINA GARASSINO

Medical Oncologist 
MD, PhD

PETER

KAUFMAN

Medical Oncologist 
MD

JOAN CARLES

Medical Oncologist 
MD, PhD

JOSEP MARIA

PIULATS

Medical

Oncologist 
MD, PhD

NIKI KARACHALIOU

Medical Oncologist 
MD, PhD

JOSÉ
PÉREZ

Medical Oncologist 
MD, PhD

ANTONIO

CALLES

Medical Oncologist MD, PhD

JAVIER GARDE

Medical Oncologist 
MD

COLLABORATORS FROM INDUSTRY AND ACADEMIA

home_fondo_you_barra_edited.jpg

FREQUENTLY ASKED QUESTIONS

home_fondo_you_barra.jpg
We're looking for you

INSIGHTS

bottom of page